Unaudited Financial Result for the Quarter and Nine Month Ended 31-Dec-25
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Triochem Products Ltd (BSE: 512101, ISIN: INE331E01013) has filed its unaudited financial results for Q3 FY26 (quarter ended 31 December 2025) and nine months FY26, as published in Navshakti and Free Press Journal on 14 February 2026. On a consolidated basis, total income from operations rose to ₹19,089.65 lakhs for 9M FY26, up sharply from ₹10,872.84 lakhs in 9M FY25, while Q3 FY26 consolidated income stood at ₹5,590.65 lakhs. Consolidated net profit after tax for 9M FY26 was ₹3,841.00 lakhs with EPS of ₹11.40 (basic and diluted). On a standalone basis, 9M FY26 total income was ₹12,893.50 lakhs with net profit of ₹1,235.20 lakhs. Equity share capital remains at ₹731.15 lakhs and reserves at ₹80,176.12 lakhs (consolidated). The Board approved the results on 13 February 2026. Notes also mention that proceeds from the sale of a unit will be utilized for the company's real estate business.
Investors should note strong consolidated revenue growth of roughly 75% year-on-year for the nine-month period, though standalone performance is more modest. The disclosure of proceeds being redeployed into a real estate business signals a possible diversification shift, which is a material strategic item worth monitoring for future quarters.